Flexible, Responsive Capital

Life Science companies utilize debt financing solutions to accelerate or broaden the scope of their clinical development, invest in new R&D or commercial infrastructures, acquire external clinical assets, extend their cash runway past important value inflection points, or shore-up their balance sheets ahead of an IPO or negotiations with strategic partners. In this vertical, Hercules Capital focuses on the following sectors:

Drug Discovery, Drug Platform, Drug Delivery, Specialty Pharma, Life Sciences Tools, Medical Devices, and more.

Work with us



R. Bryan Jadot Senior Managing Director and Group Head - Life Sciences
Janice Bourque Managing Director
Lake McGuire Managing Director
Cristy Barnes Managing Director
Michael Bowden Managing Director, Portfolio Mgmt
Mike Dutra Managing Director and Senior Investment Officer - Life Sciences
Tom Hertzberg Managing Director
Adam Soller Managing Director
Jeffrey Ralto Principal
John Miotti Principal
Brian Powers Principal

Hercules Capital is a strong long-term partner for TransMedics. The Hercules team took the time to work with the management team to understand the business opportunity and challenges that we faced. They have used that knowledge to strategically support the company throughout its key stages of development. They are more than a venture debt lender, they are a business partner that focuses on helping their portfolio companies succeed and grow. TransMedics and I are fortunate to be working with the Hercules team.

Waleed Hassanein, M.D. (President & CEO, TransMedics )


Waleed Hassanein, M.D. President and  Chief Executive Officer  of TransMedics.

We create a custom financing solution for each of our partnerships.

Contact Us

Submit a business plan to our Life Sciences Team,
or just drop us a line.

  • Max. file size: 50 MB.
  • This field is for validation purposes and should be left unchanged.